RECURRENT OVARIAN-CARCINOMA - RETREATMENT UTILIZING COMBINATION CHEMOTHERAPY INCLUDING CIS-DIAMMINEDICHLOROPLATINUM IN PATIENTS PREVIOUSLY RESPONDING TO THIS AGENT

被引：79

作者：

SELTZER, V

VOGL, S

KAPLAN, B

机构：

[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,BRONX,NY 10461

[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV MED ONCOL,BRONX,NY 10461

来源：

关键词：

D O I：

10.1016/0090-8258(85)90249-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：167 / 176

页数：10

共 23 条

[1]

AURE JC, 1971, OBSTET GYNECOL, V37, P1

[2]

BRUCKNER HW, 1981, CANCER, V47, P2288, DOI 10.1002/1097-0142(19810501)47:9<2288::AID-CNCR2820470931>3.0.CO

[3]

2-3

[4]

BRUCKNER HW, 1976, P AM ASSOC CANC RES, V17, P287

GRIFFITHS, CT ;

FULLER, AF .

[6]

HALL DJ, 1981, AM J OBSTET GYNECOL, V141, P299

[7]

PARKER LM, 1975, P AM ASSOC CANC RES, V16, P263

[8]

SMITH JP, 1972, CANCER, V30, P1565, DOI 10.1002/1097-0142(197212)30:6<1565::AID-CNCR2820300623>3.0.CO

[9]

2-H

[10] 2ND TRIAL DRUGS IN OVARIAN CANCER [J].

STANHOPE, CR ;

SMITH, JP ;

RUTLEDGE, F .